Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
29.15
-0.85 (-2.83%)
Jun 16, 2026, 4:00 PM EDT - Market closed
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.82 billion as of June 16, 2026. Its market cap has increased by 235.55% in one year.
Market Cap
1.82B
Enterprise Value
1.41B
1-Year Change
235.55%
Ranking
Category
Stock Price
$29.15
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.82B, an increase of 125.68%. That is a compound annual growth rate of 12.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 1.82B | 0.14% |
| Dec 31, 2025 | 1.81B | 210.31% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocular Therapeutix | 1.96B |
| Mineralys Therapeutics | 1.95B |
| Zai Lab | 1.92B |
| Vericel | 1.91B |
| ADMA Biologics | 1.90B |
| Lakefront Biotherapeutics NV | 1.90B |
| Rapport Therapeutics | 1.84B |
| Iovance Biotherapeutics | 1.82B |